Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)
Sheila M. Galloway(United States Military Academy), Günter Speit(Universität Ulm), Elisabeth Lorge(Servier (France)), Robert H. Heflich(National Center for Toxicological Research), Takeshi Morita(National Institute of Health Sciences), Mick D. Fellows(AstraZeneca (United Kingdom)), Marilyn J. Aardema(Procter & Gamble (United States)), David Kirkland(Covance (United Kingdom)), Anthony M. Lynch, Daniel Marzin(Institut Pasteur de Lille), David A. Eastmond, Maik Schuler(Pfizer (United States)), Dan D. Levy(United States Food and Drug Administration)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
January 20, 2011
Cited by 57
Related Papers
Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals
|Environmental and Molecular Mutagenesis|1987|661
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
|Regulatory Toxicology and Pharmacology|2006|461
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2007|437
Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster
|Proceedings of the National Academy of Sciences|2000|221
Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis
|Environmental Health Perspectives|1983|181